Current Knowledge of Acute Lung Injury and Acute Respiratory Distress Syndrome

Critical Care Nursing Clinics of North America

Volumn 24, Issue 3, 2012, Pages 377-401

  Dechert, Ronald E ^a   Haas, Carl F ^a   Ostwani, Waseem ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Cytokines; Molecular biology

Indexed keywords

AUTACOID; CYTOKINE;

ACUTE LUNG INJURY; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; CHILD; DISEASE COURSE; DRUG ANTAGONISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MOLECULARLY TARGETED THERAPY; PATHOPHYSIOLOGY; REVIEW; VENTILATOR INDUCED LUNG INJURY;

ACUTE LUNG INJURY; ADULT; CHILD; CYTOKINES; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION MEDIATORS; MOLECULAR TARGETED THERAPY; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; VENTILATOR-INDUCED LUNG INJURY;

EID: 84865359736     PISSN: 08995885     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccell.2012.06.006     Document Type: Review

References (193)

1. Ashbaugh D., Bigelow D., Petty T., et al. Acute respiratory distress in adults. Lancet 1967, 2(7511):319-323.
2. Rubenfeld G.D., Herridge M.S. Epidemiology and outcomes of acute lung injury. Chest 2007, 131(2):554-562.
3. Esteban A., Alia I., Gordo F., et al. Prospective randomized trial comparing pressure-controlled ventilation and volume-controlled ventilation in ARDS. Chest 2000, 117(6):1690-1696. Spanish Lung Failure Collaborative Group.
4. Luhr O.R., Antonsen K., Karlsson M., et al. Incidence and mortality after acute respiratory failure and acute respiratory distress syndrome in Sweden, Denmark, and Iceland: the ARF Study Group. Am J Respir Crit Care Med 1999, 159(6):1849-1861.
5. Zambon M., Vincent J.L. Mortality rates for patients with acute lung injury/ARDS have decreased over time. Chest 2008, 133(5):1120-1127.
6. Matthay M. Conference summary: acute lung injury. Chest 1999, 116(1 Suppl):119-126.
7. Ware L., Matthay M. The acute respiratory distress syndrome. N Engl J Med 2000, 342(18):1334-1349.
8. Corbridge T., Wood L., Crawford G., et al. Adverse effects of large tidal volumes and low PEEP in canine acid aspiration. Am Rev Respir Dis 1990, 142(2):311-315.
9. Dreyfuss D. Mechanical ventilation-induced pulmonary edema. Interaction with previous lung alterations. Am J Respir Crit Care Med 1995, 151(5):1568-1575.
10. Parker J., Townsley M., Rippe B., et al. Increased microvascular permeability in dog lungs due to high peak airway pressure. J Appl Physiol 1984, 57(6):1809-1816.
11. Slutsky A., Tremblay L. Multiple system organ failure: is mechanical ventilation a contributing factor?. Am J Respir Crit Care Med 1998, 157(6 Pt 1):1721-1725.
12. Webb H., Tierney D. Experimental pulmonary edema due to intermittent positive pressure ventilation with high inflation pressures: protection by positive end-expiratory pressure. Am Rev Respir Dis 1974, 110:556-561.
13. Demling R. The modern version of adult respiratory distress syndrome [review]. Ann Rev Med 1995, 46:193-202.
14. Ingbar D. Acute respiratory distress syndrome: mechanisms of repair and remodeling following acute lung injury. Clin Chest Med 2000, 21(3):589-616.
15. Lamy M., Fallat R., Koeniger E., et al. Pathologic features and mechanisms of hypoxemia in adult respiratory distress syndrome. Am Rev Respir Dis 1976, 114:267-271.
16. Tomashefski J. Pulmonary pathology of the adult respiratory distress syndrome. Clin Chest Med 1990, 11:593-619.
17. Baughman R.P., Gunther K.L., Rashkin M.C., et al. Changes in the inflammatory response of the lung during acute respiratory distress syndrome: prognostic indicators. Am J Respir Crit Care Med 1996, 154(1):76-81.
18. Meduri G.U., Kohler G., Headley S., et al. Inflammatory cytokines in the BAL of patients with ARDS: persistent elevation over time predicts poor outcome. Chest 1995, 108(5):1303-1314.
19. Dantzker D., Brook C., Dehart P., et al. Ventilation-perfusion distribution in the adult respiratory distress syndrome. Am Rev Respir Dis 1979, 120:1039-1045.
20. Ralph D., Robertson H., Weaver L., et al. Distribution of ventilation and perfusion during positive end-expiratory pressure in the adult respiratory distress syndrome. Am Rev Respir Dis 1985, 131(1):54-60.
21. Montgomery A., Stager M., Carrico C., et al. Causes of mortality in patients with adult respiratory distress syndrome. Am Rev Respir Dis 1985, 132(3):485-489.
22. Clark J., Milberg J., Steinberg K., et al. Type III procollagen peptide in adult respiratory distress syndrome: association of increased peptide levels in lavage fluid with increased risk of death. Ann Intern Med 1995, 122(1):17-23.
23. Chesnutt A.N., Matthay M.A., Tibayan F.A., et al. Early detection of type III procollagen peptide in acute lung injury: pathogenetic and prognostic significance. Am J Respir Crit Care Med 1997, 156(3 Pt 1):840-845.
24. Brower R.G., Matthay M.A., Morris A., et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000, 342(18):1301-1308.
25. Baughman R., Gunther K., Rashkin M., et al. Changes in the inflammatory response of the lung during acute respiratory distress syndrome: prognostic indicators. Am J Respir Crit Care Med 1996, 154(1):76-81.
26. Luce J. Acute lung injury and the acute respiratory distress syndrome. Crit Care Med 1998, 26(2):369-376.
27. Steinberg K., Hudson L. Acute lung injury and acute respiratory distress syndrome: the clinical syndrome. Clin Chest Med 2000, 21(3):401-417.
28. Davidson T., Caldwell E., Curtis J., et al. Reduced quality of life in survivors of acute respiratory distress syndrome with critically ill control patients. JAMA 1999, 281(4):354-360.
29. McHugh L., Milberg J., Whitcomb M., et al. Recovery of function in survivors of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1994, 150(1):90-94.
30. Schelling G., Stoll C., Hallar M. Health-related quality of life and posttraumatic disorder in survivors of acute respiratory distress syndrome. Crit Care Med 1998, 26(4):651-659.
31. Weinert C., Gross C., Kangas J., et al. Health-related quality of life after acute lung injury. Am J Respir Crit Care Med 1997, 156(4 Pt 1):1120-1128.
32. Hopkins R., Weaver L., Pope D., et al. Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome. Am J Respir Crit Care Med 1999, 160(1):50-56.
33. Hopkins R.O., Weaver L.K., Collingridge D., et al. Two year cognitive, emotional and quality-of-life outcomes in acute respiratory distress syndrome. Am J Respir Crit Care Med 2005, 171(4):340-347.
34. Dowdy D.W., Dennison C.R., Mendez-Tellez P.A., et al. Quality of life after acute respiratory distress syndrome: a meta-analysis. Intensive Care Med 2006, 32(8):1115-1124.
35. Adhikari N.K.J., Tansey C., McAndrews M., et al. Self-reported depressive symptoms and memory complaints in survivors five years after ARDS. Chest 2011, 140(6):1484-1493.
36. Gibbons M. Researchers need to study ARDS survivors after they leave the ICU The ARDS Foundation, Accessed June 30, 2012. http://www.ardsusa.org.
37. Martin T. Lung cytokines and ARDS. Chest 1999, 116(1 Suppl):2S-8S.
38. Papadakos P. Cytokines, genes, and ARDS. Chest 2002, 121(5):1391-1392.
39. Parsons P. Acute respiratory distress syndrome: mediators and mechanisms of acute lung injury. Clin Chest Med 2000, 21(3):467-476.
40. Pugin J., Ricou B., Steinberg K., et al. Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. Am J Respir Crit Care Med 1996, 153(6 Pt 1):1850-1856.
41. Pugin J., Verghese G., Widmer M.-C., et al. The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Crit Care Med 1999, 27(2):304-312.
42. Strieter R., Kunkel S., Keane M., et al. Chemokines in lung injury. Chest 1999, 116(1 Suppl):103S-105S.
43. Durbin C.G., Wallace K.K. Oxygen toxicity in the critically ill patient. Respir Care 1993, 93(7):739-750.
44. Parker J.C., Hernandez L.A., Peevy K.J. Mechanisms of ventilator-induced lung injury. Crit Care Med 1993, 21(1):131-143.
45. Dreyfuss D., Saumon G. Ventilator-induced lung injury: lessons from experimental studies. Am J Respir Crit Care Med 1998, 157(1):294-323.
46. Murphy D.B., Cregg N., Tremblay L., et al. Adverse ventilatory strategy causes pulmonary-to-systemic translocation of endotoxin. Am J Respir Crit Care Med 2000, 162(1):27-33.
47. Tremblay L., Valenza F., Ribeiro S.P., et al. Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. J Clin Invest 1997, 99(5):944-952.
48. Tremblay L.N., Slutsky A.S. Ventilator-induced injury: from barotrauma to biotrauma. Proc Assoc Am Physicians 1998, 110(6):482-488.
49. 2 clearance during mechanical ventilation is not a panacea in acute respiratory failure. Crit Care Med 2002, 30(7):1407-1412.
50. Arroliga A.C., Thompson B.T., Ancukiewicz M., et al. Use of sedatives, opioids, and neuromuscular blocking agents in patients with acute lung injury and acute respiratory distress syndrome. Crit Care Med 2008, 36(4):1083-1088. Acute Respiratory Distress Network.
51. Papazian L., Forel J.M., Gacouin A., et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010, 363(16):1107-1116.
52. Slutsky A.S. Neuromuscular blocking agents in ARDS. N Engl J Med 2010, 363(12):1176-1180.
53. Esan A., Hess D.R., Raoof S., et al. Severe hypoxemic respiratory failure: part 1-ventilatory strategies. Chest 2010, 137(5):1203-1216.
54. Brower R.G., Lanken P.N., MacIntryre N., et al. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Eng J Med 2004, 351(4):327-336.
55. Ramnath V.R., Hess D.R., Thompson B.T. Conventional mechanical ventilation in acute lung injury and acute respiratory distress syndrome. Clin Chest Med 2006, 27(4):601-613.
56. Lachmann B. Open the lung and keep the lung open. Intensive Care Med 1992, 18(6):319-321.
57. Lachmann B. Open lung in ARDS. Minerva Anesthesiol 2002, 68(9):637-642.
58. Amato M.B.P., Barbas C.S.V., Medeiros D.M., et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998, 338(6):347-354.
59. Villar J., Kacmarek R.M., Perez-Mendez L., et al. A high positive end-expiratory pressure, low tidal volume ventilation strategy improves outcome in persistent acute respiratory distress syndrome: a randomized, controlled trial. Crit Care Med 2006, 34(5):1311-1318. ARIES Network.
60. Albaiceta G.M., Luyando L.H., Parra D., et al. Inspiratory vs expiratory pressure-volume curves to set end-expiratory pressure in acute lung injury. Intensive Care Med 2005, 31(10):1370-1378.
61. Caramez M.P., Kacmarek R.M., Helmy M., et al. A comparison of methods to identify open-lung PEEP. Intensive Care Med 2009, 35(4):740-747.
62. Ranieri V.M., Zhang H., Mascia L., et al. Pressure-time curve predicts minimally injurious ventilatory strategy in an isolated rat lung model. Anesthesiol 2000, 93(5):1320-1328.
63. Grasso S., Terragni P., Mascia L., et al. Airway pressure-time curve profile (stress-index) detects tidal recruitment/hyperinflation in experimental acute lung injury. Crit Care Med 2004, 32(4):1018-1027.
64. Formenti P., Graf J., Santos A., et al. Non-pulmonary factors strongly influence the stress index. Intensive Care Med 2011, 37(4):594-600.
65. Talmor D., Sarge T., Malhotra A., et al. Mechanical ventilation guided by esophageal pressure in acute lung injury. N Engl J Med 2008, 359(20):2095-2104.
66. Talmor D.S., Fessler H.E. Are esophageal pressure measurements important in clinical decision-making in mechanically ventilated patients?. Respir Care 2010, 55(2):162-172.
67. Loring S.H., O'Donnell C.R., Behazin N., et al. Esophageal pressures in acute lung injury: do they represent artifact or useful information about transpulmonary pressure, chest wall mechanics, and lung stress?. J Appl Physiol 2010, 108(3):515-522.
68. Richard J.C.M., Marini J.J. Transpulmonoary pressure as a surrogate of plateau pressure for lung protective strategy: not perfect but more physiologic. Intensive Care Med 2012, 38(3):339-341.
69. Meade M.O., Cook D.J., Guyatt G.H., et al. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized clinical trial. JAMA 2008, 299(6):637-645.
70. Mercat A., Richard J.C.M., Vielle B., et al. Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2008, 299(6):646-655.
71. Briel M., Meade M., Mercat A., et al. Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome. JAMA 2010, 303(9):865-873.
72. Fan E., Wilcox M.E., Brower R.G., et al. Recruitment maneuvers for acute lung injury: a systematic review. Am J Respir Crit Care Med 2008, 178(11):1156-1163.
73. Kacmarek R.M., Villar J. Lung recruitment maneuvers during acute respiratory distress syndrome: is it useful?. Minerva Anestesiol 2011, 77(1):85-89.
74. Iannuzzi M., De Sio A., De Robertis E., et al. Different patterns of lung recruitment maneuvers in primary acute respiratory distress syndrome: effects on oxygenation and central hemodynamics. Minerva Anestesiol 2010, 76(9):692-698.
75. Arnal J.M., Paquet J., Wysocki M., et al. Optimal duration of a sustained inflation recruitment maneuver in ARDS patients. Intensive Care Med 2011, 37(10):1588-1594.
76. Rocco P.R., Pelosi P., de Abreu P. Pros and cons of recruitment maneuvers in acute lung injury and acute respiratory distress syndrome. Expert Rev Respir Med 2010, 4(4):479-489.
77. Downs J.B., Stock M.C. Airway pressure release ventilation: a new concept in ventilatory support. Crit Care Med 1987, 15(5):459-461.
78. Stock M.C., Downs J.B., Frolicher D.A. Airway pressure release ventilation. Crit Care Med 1987, 15(5):462-466.
79. Habashi N.M. Other approaches to open-lung ventilation: airway pressure release ventilation. Crit Care Med 2005, 33(3 Suppl):S228-S240.
80. Putensen C., Zech S., Wrigge H., et al. Long-term effects of spontaneous breathing during ventilatory support in patients with acute lung injury. Am J Respir Crit Care Med 2001, 164(1):43-49.
81. Hedenstierna G., Lichtwarck-Aschoff M. Interfacing spontaneous breathing and mechnical ventilation. Minerva Anesthesiol 2006, 72(4):183-198.
82. Rasanen J., Cane R.D., Downs J.B., et al. Airway pressure release ventilation during acute lung injury: a prospective multicenter trial. Crit Care Med 1991, 19(10):1234-1241.
83. Davis K., Johnson D.J., Branson R.D., et al. Airway pressure release ventilation. Arch Surg 1993, 128(12):1348-1352.
84. Dart B.W., Maxwell R.A., Richart C.M., et al. Preliminary experience with airway pressure release ventilation in a trauma/surgical intensive care unit. J Trauma 2005, 59(1):71-76.
85. Liu L., Tanigawa K., Ota K., et al. Practical use of airway pressure release ventilation for severe ARDS-a preliminary report in comparison with a conventional ventilatory support. Hiroshima J Med Sci 2009, 58(4):83-88.
86. Varpula T., Valta P., Niemi R., et al. Airway pressure release ventilation as a primary ventilatory mode in acute respiratory distress syndrome. Acta Anaesthesiol Scand 2004, 48(6):722-731.
87. Varpula T., Valta P., Markkola A., et al. The effects of ventilatory mode on lung aeration assessed with computer tomography: a randomized controlled study. J Intensive Care Med 2009, 24(2):122-130.
88. Maxwell R.A., Green J.M., Waldrop J., et al. A randomized prospective trial of airway pressure release ventilation and low tidal volume ventilation in adult trauma patients with acute respiratory failure. J Trauma 2010, 69:501-511.
89. Imai I., Slutsky A.S. High-frequency oscillatory ventilation and ventilator-induced lung injury. Crit Care Med 2005, 33(3 Suppl):S129-S134.
90. Hager D.N., Fessler H.E., Kaczka D.W., et al. Tidal volume delivery during high-frequency oscillatory ventilation in adults with acute respiratory distress syndrome. Crit Care Med 2007, 35(6):1522-1529.
91. Rotta A.T., Gunnarsson B., Fuhrman B.P., et al. Comparison of lung protective ventilation strategies in a rabbit model of acute lung injury. Crit Care Med 2001, 29(11):2176-2184.
92. Hamilton P.P., Onayemi A., Smyth J.A., et al. Comparison of conventional and high frequency ventilation: oxygenation and lung pathology. J Appl Physiol 1983, 55(1):131-138.
93. Muellenbach R.M., Kredel M., Said H.M., et al. High-frequency oscillatory ventilation reduces lung inflammation: a large-animal 24-h model of respiratory distress. Intensive Care Med 2007, 33(8):1423-1433.
94. Imai Y., Nakagawa S., Ito Y., et al. Comparison of lung protection strategies using conventional and high-frequency oscillatory ventilation. J Appl Physiol 2001, 91(4):1836-1844.
95. Fort P., Farmer C., Westerman J., et al. High-frequency oscillatory ventilation for adult respiratory distress syndrome-a pilot study. Crit Care Med 1997, 25(6):937-947.
96. Mehta S., Lapinsky S.E., Hallett D.C., et al. Prospective trial of high-frequency oscillation in adults with acute respiratory distress syndrome. Crit Care Med 2001, 29(7):1360-1369.
97. Anderson F.A., Guttormsen A.B., Flaatten H.K. High frequency oscillatory ventilation in adult patients with acute respiratory distress syndrome-a retrospective study. Acta Anaesthesiol Scand 2002, 46(9):1082-1088.
98. David M., Weiler N., Heinrichs W., et al. High-frequency oscillatory ventilation in adult acute respiratory distress syndrome. Intensive Care Med 2003, 29(10):1656-1665.
99. Cartotto R., Ellis S., Gomez M., et al. High frequency oscillatory ventilation in burn patients with the acute respiratory distress syndrome. Burns 2004, 30(5):453-463.
100. Ferguson N.D., Chiche J.D., Kacmarek R.M., et al. Combining high-frequency oscillatory ventilation and recruitment maneuvers in adults with early respiratory distress syndrome: the treatment with oscillation and an open lung strategy (TOOLS) trial pilot study. Crit Care Med 2005, 33(3):479-486.
101. Pachl J., Roubik K., Waldauf P., et al. Normocapnic high-frequency oscillatory ventilation affects differently extrapulmonary and pulmonary forms of acute respiratory distress syndrome in adults. Physiol Res 2006, 55(1):15-24.
102. Finkielman J.D., Gajic O., Farmer J.C., et al. The initial Mayo Clinic experience using high-frequency oscillatory ventilation for adult patients: a retrospective study. BMC Emerg Med 2006, 6(2):1-8.
103. Kao K.C., Tsai Y.H., Wu Y.K., et al. High frequency oscillatory ventilation for surgical patients with acute respiratory distress syndrome. J Trauma 2006, 61(4):837-843.
104. Derdak S., Mehta S., Stewart T.E., et al. High-frequency oscillatory ventilation for acute respiratory distress syndrome in adults: a randomized, controlled trial. Am J Respir Crit Care Med 2002, 166(6):801-808.
105. Bollen C.W., van Well G.T.J., Sherry T., et al. High frequency oscillatory ventilation compared with conventional mechanical ventilation in adult respiratory distress syndrome: a randomized controlled trial. Crit Care 2005, 9:R430-R439.
106. Papazian L., Gainnier M., Marin V., et al. Comparison of prone positioning and high-frequency oscillatory ventilation in patients with acute respiratory distress syndrome. Crit Care Med 2005, 33(10):2162-2171.
107. Demory D., Michelet P., Arnal J.M., et al. High frequency oscillatory ventilation following prone positioning prevents a further impairment in oxygenation. Crit Care Med 2007, 35(1):106-111.
108. Fessler H.E., Derdak S., Ferguson N.D., et al. A protocol for high-frequency oscillatory ventilation in adults: results from a roundtable discussion. Crit Care Med 2007, 35(7):1649-1654.
109. Fessler H.E., Hager D.N., Brower R.G. Feasibility of very high-frequency ventilation in adults with acute respiratory distress syndrome. Crit Care Med 2008, 36(4):1043-1048.
110. Griffiths M.J., Evans T.W. Inhaled nitric oxide therapy in adults. N Engl J Med 2005, 353(25):2683-2695.
111. Payen D.M. Inhaled nitric oxide and acute lung injury. Clin Chest Med 2000, 21(3):519-529. ix.
112. Puybasset L., Rouby J.J. Pulmonary uptake and modes of administration of inhaled nitric oxide in mechanically-ventilated patients. Crit Care 1998, 2:9-17.
113. Rossaint R., Falke K.J., Lopez F., et al. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993, 328(6):399-405.
114. Adnot S., Raffestin B., Eddahibi S. NO in the lung. Respir Physiol 1995, 101(2):109-120.
115. Pison U., Lopez F.A., Heidelmeyer C.F., et al. Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction without impairing gas exchange. J Appl Physiol 1993, 74:1287-1292.
116. Creagh-Brown B.C., Griffiths M.J., Evans T.W. Bench-to-bedside review: inhaled nitric oxide therapy in adults. Crit Care 2009, 13(3):221.
117. Dellinger R.P., Zimmerman J.L., Taylor R.W., et al. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Crit Care Med 1998, 26(1):15-23. Inhaled Nitric Oxide in ARDS Study Group.
118. Troncy E., Collet J.P., Shapiro S., et al. Inhaled nitric oxide in acute respiratory distress syndrome: a pilot randomized controlled study. Am J Respir Crit Care Med 1998, 157(5 Pt 1):1483-1488.
119. Michael J.R., Barton R.G., Saffle J.R., et al. Inhaled nitric oxide versus conventional therapy: effect on oxygenation in ARDS. Am J Respir Crit Care Med 1998, 157(5 Pt 1):1372-1380.
120. Taylor R.W., Zimmerman J.L., Dellinger R.P., et al. Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. JAMA 2004, 291(13):1603-1609.
121. Lundin S., Mang H., Smithies M., et al. Inhalation of nitric oxide in acute lung injury: results of a European multicentre study. Intensive Care Med 1999, 25(9):911-919. The European Study Group of Inhaled Nitric Oxide.
122. Adhikari N.K., Burns K.E., Friedrich J.O., et al. Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis. BMJ 2007, 334(7597):779.
123. Abman S.H., Griebel J.L., Parker D.K., et al. Acute effects of inhaled nitric oxide in children with severe hypoxemic respiratory failure. J Pediatr 1994, 124(6):881-888.
124. Dobyns E.L., Cornfield D.N., Anas N.G., et al. Multicenter randomized controlled trial of the effects of inhaled nitric oxide therapy on gas exchange in children with acute hypoxemic respiratory failure. J Pediatr 1999, 134(4):406-412.
125. Dobyns E.L., Anas N.G., Fortenberry J.D., et al. Interactive effects of high-frequency oscillatory ventilation and inhaled nitric oxide in acute hypoxemic respiratory failure in pediatrics. Crit Care Med 2002, 30(11):2425-2429.
126. Warren J.B., Higenbottam T. Caution with use of inhaled nitric oxide. Lancet 1996, 348(9028):629-630.
127. Quinn A.C., Petros A.J., Vallance P. Nitric oxide: an endogenous gas. Br J Anaesth 1995, 74(4):443-451.
128. Zabrocki L.A., Brogan T.V., Statler K.D., et al. Extracorporeal membrane oxygenation for pediatric respiratory failure: survival and predictors of mortality. Crit Care Med 2011, 39(2):364-370.
129. Moler F.W., Palmisano J.M., Green T.P., et al. Predictors of outcome of severe respiratory syncytial virus-associated respiratory failure treated with extracorporeal membrane oxygenation. J Pediatr 1993, 123(1):46-52.
130. Green T.P., Moler F.W., Goodman D.M. Probability of survival after prolonged extracorporeal membrane oxygenation in pediatric patients with acute respiratory failure. Crit Care Med 1995, 23(6):1132-1139. Extracorporeal Life Support Organization.
131. Pranikoff T., Hirschl R.B., Steimle C.N., et al. Mortality is directly related to the duration of mechanical ventilation before the initiation of extracorporeal life support for severe respiratory failure. Crit Care Med 1997, 25(1):28-32.
132. Arnold J.H., Hanson J.H., Toro-Figuero L.O., et al. Prospective, randomized comparison of high-frequency oscillatory ventilation and conventional mechanical ventilation in pediatric respiratory failure. Crit Care Med 1994, 22(10):1530-1539.
133. Trachsel D., McCrindle B.W., Nakagawa S., et al. Oxygenation index predicts outcome in children with acute hypoxemic respiratory failure. Am J Respir Crit Care Med 2005, 172(2):206-211.
134. Hemmila M.R., Rowe S.A., Boules T.N., et al. Extracorporeal life support for severe acute respiratory distress syndrome in adults. Ann Surg 2004, 240(4):595-605. [discussion: 605-7].
135. Rollins M.D., Hubbard A., Zabrocki L., et al. Extracorporeal membrane oxygenation cannulation trends for pediatric respiratory failure and central nervous system injury. J Pediatr Surg 2012, 47:68-75.
136. Zahraa J.N., Moler F.W., Annich G.M., et al. Venovenous versus venoarterial extracorporeal life support for pediatric respiratory failure: are there differences in survival and acute complications?. Crit Care Med 2000, 28(2):521-525.
137. Peek G.J., Mugford M., Tiruvoipati R., et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009, 374(9698):1351-1363.
138. Ware L.B., Matthay M.A. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001, 163(6):1376-1383.
139. Pittet J.F., Wiener-Kronish J.P., McElroy M.C., et al. Stimulation of lung epithelial liquid clearance by endogenous release of catecholamines in septic shock in anesthetized rats. J Clin Invest 1994, 94(2):663-671.
140. Perkins G.D., McAuley D.F., Thickett D.R., et al. The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial. Am J Respir Crit Care Med 2006, 173(3):281-287.
141. Perkins G.D., McAuley D.F. Pro: beta-agonists in acute lung injury-the end of the story?. Am J Respir Crit Care Med 2011, 184(5):503-504.
142. 2-adrenergic agonists in ALI/ARDS-not recommended or potentially harmful?. Am J Respir Crit Care Med 2011, 184(5):504-506.
143. Thompson B.T. Beta-agonists for ARDS: the dark side of adrenergic stimulation?. Lancet 2012, 379:196-198.
144. Matthay M.A., Brower R.G., Carson S., et al. Randomized, placebo-controlled clinical trial of an aerosolized beta-agonist for treatment of acute lung injury. Am J Respir Crit Care Med 2011, 184(5):561-568.
145. Au D.H., Curtis J.R., Every N.R., et al. Association between inhaled beta-agonists and the risk of unstable angina and myocardial infarction. Chest 2002, 121(3):846-851.
146. Modelska K., Matthay M.A., Brown L.A., et al. Inhibition of beta-adrenergic-dependent alveolar epithelial clearance by oxidant mechanisms after hemorrhagic shock. Am J Physiol 1999, 276(5 Pt 1):L844-L857.
147. Frank J.A., Pittet J.F., Lee H., et al. High tidal volume ventilation induces NOS2 and impairs cAMP-dependent air space fluid clearance. Am J Physiol Lung Cell Mol Physiol 2003, 284(5):L791-L798.
148. Sartori C., Allemann Y., Duplain H., et al. Salmeterol for the prevention of high-altitude pulmonary edema. N Engl J Med 2002, 346(21):1631-1636.
149. Licker M., Tschopp J.M., Robert J., et al. Aerosolized salbutamol accelerates the resolution of pulmonary edema after lung resection. Chest 2008, 133(4):845-852.
150. Perkins G.D., Park D., Alderson D., et al. The Beta Agonist Lung Injury Trial (BALTI)- prevention trial protocol. Trials 2011, 12:79.
151. Ware L.B., Koyama T., Billheimer D., et al. Advancing donor management research: design and implementation of a large, randomized, placebo-controlled trial. Ann Intensive Care 2011, 1:20.
152. +-ATPase pump in a mouse model in vivo augments resolution of high permeability pulmonary oedema. Gene Ther 2000, 7(11):960-966.
153. Luster A.D., Alon R., von Andrian U.H. Immune cell migration in inflammation: present and future therapeutic targets. Nat Immunol 2005, 6:1182-1190.
154. Lawrence M.B., Springer T.A. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell 1991, 65:859-873.
155. Butcher E.C. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 1991, 67:1033-1036.
156. Orlova V.V., Chavakis T. Regulation of vascular endothelial permeability by junctional adhesion molecules (JAM). Thromb Haemost 2007, 98:327-332.
157. Ley K., Laudanna C., Cybulsky M.I., et al. Getting to the site of inflammation: the leuhocyte adhesion cascade update. Nat Rev Immunol 2007, 7:678-689.
158. Rao R.M., Yang L., Garcia-Cardena G., et al. Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall. Circ Res 2007, 101:234-237.
159. Schenekl A.R., Mamdouh Z., Muller W.A. Locomotion of monocytes on endothelium is a critical step suring extravasation. Nat Immunol 2004, 5:393-400.
160. Imhof B.A., Aurrand-Lions M. Adhesion mechanisms regulating the migration of monocytes. Nat Rev Immunol 2004, 4:432-444.
161. Kinashi T. Intracellular signalling controlling integrin activation in lymphocytes. Nat Rev Immunol 2005, 5:546-559.
162. Vestweber D. Adhesion and signalling molecules controlling the transmigration of leukocytes through endothelium. Immunol Rev 2007, 218:178-196.
163. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994, 76:301-314.
164. Kumasaka T., Quinlan W.M., Doyle N.A., et al. Role of the intercellular adhesion molecule-1(ICAM-1) in endotoxin-induced pneumonia evaluated using ICAM-1 antisense oligonucleotides, anti-ICAM-1 monoclonal antibodies, and ICAM-1 mutant mice. J Clin Invest 1996, 97:2362-2369.
165. Doerschuk C.M., Quinlan W.M., Doyle N.A., et al. The role of P-selectin and ICAM-1 in acute lung injury as determined using blocking antibodies and mutant mice. J Immunol 1996, 157(10):4609-4614.
166. Ridings P.C., Windsor A.C., Jutila M.A., et al. A dual-binding antibody to E- and L-selectin attenuates sepsis-induced lung injury. Am J Respir Crit Care Med 1995, 152(1):247-253.
167. Mulligan M.S., Miyasaka M., Tamatani T., et al. Requirements for L-selectin in neutrophil-mediated lung injury in rats. J Immunol 1994, 152(2):832-840.
168. Mulligan M.S., Polley M.J., Bayer R.J., et al. Neutrophil-dependent acute lung injury: requirement for P-selectin (GMP-140). J Clin Invest 1992, 90(4):1600-1607.
169. Etzioni A., Alon R. Leukocyte adhesion deficiency III: a group of integrin activation defects in hematopoietic lineage cells. Curr Opin Allergy Clin Immunol 2004, 4(6):485-490.
170. Kinashi T., Aker M., Sokolovsky-Eisenberg M., et al. LAD-III, a leukocyte adhesion deficiency syndrome associated with defective Rap1 activation and impaired stabilization of integrin bonds. Blood 2004, 103(3):1033-1036.
171. Bogdan C., Vodovotz Y., Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 1991, 174(6):1549-1555.
172. Bogdan C., Paik J., Vodovotz Y., et al. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. J Biol Chem 1992, 267(32):23301-23308.
173. DeVries A., Semchuk W.M., Betcher J.G. Ketoconazole in the prevention of acute respiratory distress syndrome. Pharmacotherapy 1998, 18(3):581-587.
174. Williams J.G., Maier R.V. Ketoconazole inhibits alveolar macrophage production of inflammatory mediators involved in acute lung injury (adult respiratory distress syndrome). Surgery 1992, 112(2):270-277.
175. Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndrome. Crit Care Med 2002, 30:1-6. The ARDS Clinical Trials Network, National Heart Lung, and Blood Institute, National Institutes of Health.
176. Bone R.C. Why sepsis trials fail. JAMA 1996, 276(7):565-566.
177. Fisher C.J., Agosti J.M., Opal S.M., et al. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. N Engl J Med 1996, 334:1697-1702. Soluble TNF Receptor Sepsis Study Group.
178. Lemeshow S., Teres D., Moseley S. Statistical issues in clinical sepsis trials 1996, Williams & Wilkins, Baltimore (MD).
179. Yanik G.A., Ho V.T., Levine J.E., et al. The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation. Blood 2008, 112(8):3073-3081.
180. Panoskaltsis-Mortari A., Griese M., Madtes D.K., et al. An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome. Am J Respir Crit Care Med 2011, 183(9):1262-1279.
181. Matsumoto T., Yokoi K., Mukaida N., et al. Pivotal role of interleukin-8 in the acute respiratory distress syndrome and cerebral reperfusion injury. J Leukoc Biol 1997, 62(5):581-587.
182. Folkesson H.G., Matthay M.A., Hebert C.A., et al. Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms. J Clin Invest 1995, 96(1):107-116.
183. Mulligan M.S., Jones M.L., Bolanowski M.A., et al. Inhibition of lung inflammatory reactions in rats by an anti-human IL-8 antibody. J Immunol 1993, 150(12):5585-5595.
184. Kurdowska A., Noble J.M., Steinberg K.P., et al. Anti-interleukin 8 autoantibody: interleukin 8 complexes in the acute respiratory distress syndrome. Relationship between the complexes and clinical disease activity. Am J Respir Crit Care Med 2001, 163(2):463-468.
185. Krupa A., Kato H., Matthay M.A., et al. Proinflammatory activity of anti-IL-8 autoantibody:IL-8 complexes in alveolar edema fluid from patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol 2004, 286(6):L1105-L1113.
186. Ponath P.D. Chemokine receptor antagonists: novel therapeutics for inflammation and AIDS. Expert Opin Invest Drugs 1998, 7:1-18.
187. Mehta N.M., Arnold J.H. Genetic polymorphisms in acute respiratory distress syndrome: new approach to an old problem. Crit Care Med 2005, 33(10):2443-2445.
188. Floros J., Pavlovic J. Genetics of acute respiratory distress syndrome: challenges, approaches, surfactant proteins as candidate genes. Semin Respir Crit Care Med 2003, 24(2):161-168.
189. Shanley T.P., Wong H.R. Molecular genetics in the pediatric intensive care unit. Crit Care Clin 2003, 19(3):577-594.
190. Lin Z., Pearson C., Chinchilli V., et al. Polymorphisms of human SP-A, SP-B, and SP-D genes: association of SP-B Thr131Ile with ARDS. Clin Genet 2000, 58(6):181-191.
191. Nogee L.M., Dunbar A.E., Wert S.E., et al. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 2001, 344(8):573-579.
192. Stuber F., Petersen M., Bokelmann F., et al. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit Care Med 1996, 24(2):381-384.
193. Mira J.P., Cariou A., Grall F., et al. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 1999, 282(6):561-568.